1. Genetic switch selectively kills hepatocellular carcinoma cell based on microRNA and tissue-specific promoter.
- Author
-
Lu YY, Li Y, Chen ZL, Xiong XH, Wang QY, Dong HL, Zhu C, Cui JZ, Hu A, Wang L, Song N, Liu G, and Chen HP
- Subjects
- Humans, Genes, Reporter, Hep G2 Cells, Cell Line, Tumor, Cell Survival genetics, Gene Expression Regulation, Neoplastic, Green Fluorescent Proteins metabolism, Green Fluorescent Proteins genetics, Organ Specificity genetics, MicroRNAs genetics, MicroRNAs metabolism, Carcinoma, Hepatocellular genetics, Carcinoma, Hepatocellular pathology, Carcinoma, Hepatocellular metabolism, Liver Neoplasms genetics, Liver Neoplasms pathology, Promoter Regions, Genetic genetics
- Abstract
The clinical treatment of hepatocellular carcinoma (HCC) is still a heavy burden worldwide. Intracellular microRNAs (miRNAs) commonly express abnormally in cancers, thus they are potential therapeutic targets for cancer treatment. miR-21 is upregulated in HCC whereas miR-122 is enriched in normal hepatocyte but downregulated in HCC. In our study, we first generated a reporter genetic switch compromising of miR-21 and miR-122 sponges as sensor, green fluorescent protein (GFP) as reporter gene and L7Ae:K-turn as regulatory element. The reporter expression was turned up in miR-21 enriched environment while turned down in miR-122 enriched environment, indicating that the reporter switch is able to respond distinctly to different miRNA environment. Furthermore, an AAT promoter, which is hepatocyte-specific, is applied to increase the specificity to hepatocyte. A killing switch with AAT promoter and an apoptosis-inducing element, Bax, in addition to miR-21 and miR-122 significantly inhibited cell viability in Huh-7 by 70 % and in HepG2 by 60 %. By contrast, cell viability was not affected in five non-HCC cells. Thus, we provide a novel feasible strategy to improve the safety of miRNA-based therapeutic agent to cancer., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF